Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

erythropoiesis-stimulating agent

(eh-RITH-roh-poy-EE-sis-STIM-yoo-LAY-ting AY-jent)

A substance that stimulates the bone marrow to make more red blood cells. Erythropoiesis-stimulating agents are used to treat anemia caused by chronic kidney failure, some anticancer drugs, and certain treatments for HIV. They may also be used to lower the number of blood transfusions needed during and after certain major surgeries. Examples of erythropoiesis-stimulating agents are epoetin alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp). Also called ESA.

erythropoiesis-stimulating agent

Search NCI's Dictionary of Cancer Terms